Biofarm (BSE:BIO) FCF Margin % : -7.60% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Biofarm FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biofarm's Free Cash Flow for the three months ended in Mar. 2024 was lei-5.4 Mil. Biofarm's Revenue for the three months ended in Mar. 2024 was lei71.5 Mil. Therefore, Biofarm's FCF Margin % for the quarter that ended in Mar. 2024 was -7.60%.

As of today, Biofarm's current FCF Yield % is 3.34%.

The historical rank and industry rank for Biofarm's FCF Margin % or its related term are showing as below:

BSE:BIO' s FCF Margin % Range Over the Past 10 Years
Min: -0.4 Med: 11.62 Max: 27.22
Current: 2.73

During the past 13 years, the highest FCF Margin % of Biofarm was 27.22%. The lowest was -0.40%. And the median was 11.62%.

BSE:BIO's FCF Margin % is ranked better than
57.38% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs BSE:BIO: 2.73

Biofarm FCF Margin % Historical Data

The historical data trend for Biofarm's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm FCF Margin % Chart

Biofarm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

27.22

5.55

19.97

-0.40

17.83

Biofarm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															39.19	-8.84	33.22	-7.66	-7.60

Competitive Comparison of Biofarm's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofarm's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biofarm's FCF Margin % falls into.

Biofarm FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biofarm's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	49.986	/	280.289
	=	17.83 %

Biofarm's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-5.434	/	71.524
	=	-7.60 %

Biofarm FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biofarm's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofarm (BSE:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website

https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.